These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29857007)

  • 1. Rift Valley fever in animals and humans: Current perspectives.
    McMillen CM; Hartman AL
    Antiviral Res; 2018 Aug; 156():29-37. PubMed ID: 29857007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rift Valley fever, Mayotte, 2007-2008.
    Sissoko D; Giry C; Gabrie P; Tarantola A; Pettinelli F; Collet L; D'Ortenzio E; Renault P; Pierre V
    Emerg Infect Dis; 2009 Apr; 15(4):568-70. PubMed ID: 19331733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal.
    Javelle E; Lesueur A; Pommier de Santi V; de Laval F; Lefebvre T; Holweck G; Durand GA; Leparc-Goffart I; Texier G; Simon F
    Ann Clin Microbiol Antimicrob; 2020 Jan; 19(1):4. PubMed ID: 31969141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift Valley Fever Reemergence after 7 Years of Quiescence, South Africa, May 2018.
    Jansen van Vuren P; Kgaladi J; Msimang V; Paweska JT
    Emerg Infect Dis; 2019 Feb; 25(2):338-341. PubMed ID: 30666946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districts.
    Murithi RM; Munyua P; Ithondeka PM; Macharia JM; Hightower A; Luman ET; Breiman RF; Njenga MK
    Epidemiol Infect; 2011 Mar; 139(3):372-80. PubMed ID: 20478084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus.
    Connors KA; Hartman AL
    Annu Rev Virol; 2022 Sep; 9(1):437-450. PubMed ID: 36173701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-epidemic and between-season persistence of rift valley fever: vertical transmission or cryptic cycling?
    Manore CA; Beechler BR
    Transbound Emerg Dis; 2015 Feb; 62(1):13-23. PubMed ID: 23551913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa?
    Baba M; Masiga DK; Sang R; Villinger J
    Emerg Microbes Infect; 2016 Jun; 5(6):e58. PubMed ID: 27329846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rift Valley Fever in Egypt and other African countries: Historical review, recent outbreaks and possibility of disease occurrence in Egypt.
    Kenawy MA; Abdel-Hamid YM; Beier JC
    Acta Trop; 2018 May; 181():40-49. PubMed ID: 29391128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for the Rift Valley fever occurrence in China: Special concern in south-west border areas.
    Liu B; Ma J; Jiao Z; Gao X; Xiao J; Wang H
    Transbound Emerg Dis; 2021 Mar; 68(2):445-457. PubMed ID: 32568445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?
    Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE
    Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2007 Rift Valley fever outbreak in Sudan.
    Hassan OA; Ahlm C; Sang R; Evander M
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1229. PubMed ID: 21980543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous High Rainfall and Soil Saturation as Combined Risk Indicator of Rift Valley Fever Outbreaks, South Africa, 2008-2011.
    Williams R; Malherbe J; Weepener H; Majiwa P; Swanepoel R
    Emerg Infect Dis; 2016 Dec; 22(12):2054-2062. PubMed ID: 27403563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the 2017-2018 Rift valley fever outbreak in Yirol East County, South Sudan: a one health perspective.
    Ramadan OPC; Berta KK; Wamala JF; Maleghemi S; Rumunu J; Ryan C; Ladu AI; Joseph JLK; Abenego AA; Ndenzako F; Olu OO
    Pan Afr Med J; 2022; 42(Suppl 1):5. PubMed ID: 36158935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007.
    Sindato C; Karimuribo ED; Pfeiffer DU; Mboera LE; Kivaria F; Dautu G; Bernard B; Paweska JT
    PLoS One; 2014; 9(2):e88897. PubMed ID: 24586433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review.
    Fawzy M; Helmy YA
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30736362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rift Valley fever: could re-emerge in Egypt again?
    El-Bahnasawy M; Megahed LA; Abdalla Saleh HA; Morsy TA
    J Egypt Soc Parasitol; 2013 Apr; 43(1):41-56. PubMed ID: 23697015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Rift Valley fever may present with a characteristic clinical syndrome.
    Kahlon SS; Peters CJ; Leduc J; Muchiri EM; Muiruri S; Njenga MK; Breiman RF; White AC; King CH
    Am J Trop Med Hyg; 2010 Mar; 82(3):371-5. PubMed ID: 20207858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.